Literature DB >> 6489431

Effect of age and sex on the plasma binding of acidic and basic drugs.

R K Verbeeck, J A Cardinal, S M Wallace.   

Abstract

Protein binding of chlorpromazine, propranolol, meperidine, desipramine, salicylic acid and phenytoin was determined in plasma of 64 healthy volunteers (35 males and 29 females). An attempt was made to identify factors affecting the plasma protein binding of these drugs. Whereas plasma albumin levels decreased as a function of age in both sexes, alpha 1-acid glycoprotein levels increased with age, but the increase was more pronounced in males. The free plasma fraction of the acidic drugs (salicylic acid, phenytoin) and desipramine (a base) showed a significant (p less than 0.005) negative correlation with plasma albumin levels. The free fractions of the other three basic drugs (chlorpromazine, propranolol, meperidine) in plasma showed a significant (p less than 0.005) negative correlation with alpha 1-acid glycoprotein plasma levels. Plasma protein binding of salicylic acid, phenytoin and desipramine decreased as a function of age. Plasma protein binding of chlorpromazine, propranolol and meperidine was virtually unaffected by age or was slightly increased (chlorpromazine). Only in the case of salicylic acid could a statistically significant difference be demonstrated between males and females in the free fraction-age relationship. Stepwise multiple linear regression analysis, including age and blood chemistry values such as hematocrit, bilirubin, cholesterol, triglycerides, creatinine, BUN, albumin and alpha 1-acid glycoprotein as independent variables, identified age as the variable explaining most of the variability in plasma binding of salicylic acid, phenytoin and desipramine. For chlorpromazine, propranolol and meperidine alpha 1-acid glycoprotein was the most important determinant of plasma protein binding.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6489431

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  36 in total

1.  Factors affecting drug binding in plasma of elderly patients.

Authors:  S Wallace; B Whiting
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

Review 2.  Drug use in the elderly: a review of problems and special considerations.

Authors:  R E Vestal
Journal:  Drugs       Date:  1978-10       Impact factor: 9.546

3.  Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function.

Authors:  M M Reidenberg; I Odar-Cederlöf; C von Bahr; O Borgå; F Sjöqvist
Journal:  N Engl J Med       Date:  1971-07-29       Impact factor: 91.245

4.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

5.  Meperidine kinetics in man. Intravenous injection in surgical patients and volunteers.

Authors:  L E Mather; G T Tucker; A E Pflug; M J Lindop; C Wilkerson
Journal:  Clin Pharmacol Ther       Date:  1975-01       Impact factor: 6.875

6.  Effect of age and gender on disposition of temazepam.

Authors:  M Divoll; D J Greenblatt; J S Harmatz; R I Shader
Journal:  J Pharm Sci       Date:  1981-10       Impact factor: 3.534

7.  Oxazepam kinetics: effects of age and sex.

Authors:  D J Greenblatt; M Divoll; J S Harmatz; R I Shader
Journal:  J Pharmacol Exp Ther       Date:  1980-10       Impact factor: 4.030

8.  Sex differences in absorption kinetics of sodium salicylate.

Authors:  S L Miaskiewicz; C A Shively; E S Vesell
Journal:  Clin Pharmacol Ther       Date:  1982-01       Impact factor: 6.875

9.  Plasma protein binding of drugs as a function of age in adult human subjects.

Authors:  A D Bender; A Post; J P Meier; J E Higson; G Reichard
Journal:  J Pharm Sci       Date:  1975-10       Impact factor: 3.534

10.  Effects of cancer and its treatments on plasma concentration of alpha 1-acid glycoprotein and propranolol binding.

Authors:  F P Abramson; J Jenkins; Y Ostchega
Journal:  Clin Pharmacol Ther       Date:  1982-11       Impact factor: 6.875

View more
  31 in total

Review 1.  Age-related changes in protein binding of drugs: implications for therapy.

Authors:  M K Grandison; F D Boudinot
Journal:  Clin Pharmacokinet       Date:  2000-03       Impact factor: 6.447

Review 2.  Methods of determining plasma and tissue binding of drugs. Pharmacokinetic consequences.

Authors:  G M Pacifici; A Viani
Journal:  Clin Pharmacokinet       Date:  1992-12       Impact factor: 6.447

Review 3.  Hepatic drug metabolism and aging.

Authors:  C Durnas; C M Loi; B J Cusack
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

Review 4.  Prescribing antiepileptics for the elderly: differences between guideline recommendations and clinical practice.

Authors:  Mary Jo V Pugh; Perry J Foreman; Dan R Berlowitz
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

5.  The effect of age on serum concentrations of albumin and alpha 1-acid glycoprotein.

Authors:  B T Veering; A G Burm; J H Souverijn; J M Serree; J Spierdijk
Journal:  Br J Clin Pharmacol       Date:  1990-02       Impact factor: 4.335

6.  Pharmacokinetics of phenytoin: reminders and discoveries.

Authors:  Donna C Bergen
Journal:  Epilepsy Curr       Date:  2009 Jul-Aug       Impact factor: 7.500

7.  Age does not influence the serum protein binding of bupivacaine.

Authors:  B T Veering; A G Burm; M P Gladines; J Spierdijk
Journal:  Br J Clin Pharmacol       Date:  1991-10       Impact factor: 4.335

8.  The aging liver. Drug clearance and an oxygen diffusion barrier hypothesis.

Authors:  D G Le Couteur; A J McLean
Journal:  Clin Pharmacokinet       Date:  1998-05       Impact factor: 6.447

Review 9.  Drug treatment of epilepsy in elderly people: focus on valproic Acid.

Authors:  Linda J Stephen
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 10.  Selecting neuromuscular-blocking drugs for elderly patients.

Authors:  Tristan M Cope; Jennifer M Hunter
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.